Institutional Ownership Tarsus Pharmaceuticals, Inc. (TARS)
This table provides information about the institutional ownership of Tarsus Pharmaceuticals, Inc. (TARS). We have compiled data on the 170 institutions that hold shares in the stock, with a total of 43.3 Million shares, which have been reported (via 13F filing form) to have a value of $2.02 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Rtw Investments, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
3,412,486
shares
|
$153 Million
1.79% of portfolio
|
Q2 2024
Added 4.28%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,266,714
shares
|
$146 Million
0.0% of portfolio
|
Q2 2024
Added 23.15%
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Nov 14, 2024 Q3 2024 |
2,440,445
shares
|
$109 Million
2.89% of portfolio
|
Q3 2024
Added 0.21%
|
|
Tang Capital Management LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
2,254,797
shares
|
$101 Million
6.32% of portfolio
|
Q1 2024
Added 2.27%
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
2,208,588
shares
|
$99 Million
0.01% of portfolio
|
Q3 2024
Added 17.19%
|
|
Cowen And Company, LLC
|
Nov 12, 2024 Q3 2024 |
2,197,385
shares
|
$98.5 Million
1.86% of portfolio
|
Q2 2024
Added 3.53%
|
|
Jennison Associates LLC
|
Nov 08, 2024 Q3 2024 |
2,178,580
shares
|
$97.7 Million
0.04% of portfolio
|
Q3 2024
Added 47.21%
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
2,097,323
shares
|
$94 Million
0.0% of portfolio
|
Q3 2024
Added 5.41%
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Nov 15, 2024 Q3 2024 |
1,587,527
shares
|
$71.2 Million
2.81% of portfolio
|
Q2 2024
Reduced 11.19%
|
|
Perceptive Advisors LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
1,296,416
shares
|
$58.1 Million
1.11% of portfolio
|
Q4 2020
New holding
|
|
Assenagon Asset Management S.A.
|
Oct 23, 2024 Q3 2024 |
1,141,247
shares
|
$51.2 Million
0.08% of portfolio
|
Q3 2024
Added 7.32%
|
|
Ikarian Capital, LLC
Dallas, TX |
Nov 14, 2024 Q3 2024 |
1,030,277
shares
|
$46.2 Million
5.92% of portfolio
|
Q3 2024
Added 28.74%
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
899,379
shares
|
$40.3 Million
0.0% of portfolio
|
Q3 2024
Reduced 2.84%
|
|
Exodus Point Capital Management, LP
New York, NY |
Nov 12, 2024 Q3 2024 |
883,043
shares
|
$39.6 Million
0.18% of portfolio
|
Q3 2024
Added 31.71%
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
835,790
shares
|
$37.5 Million
0.0% of portfolio
|
Q3 2024
Added 8.09%
|
|
Artisan Partners Limited Partnership
Milwaukee, WI |
Nov 12, 2024 Q3 2024 |
709,018
shares
|
$31.8 Million
0.04% of portfolio
|
Q3 2024
Added 12.98%
|
|
Invesco Ltd.
Atlanta, GA |
Nov 12, 2024 Q3 2024 |
682,097
shares
|
$30.6 Million
0.0% of portfolio
|
Q3 2024
Added 74.2%
|
|
Tfg Asset Management Gp LTD
Grand Cayman, E9 |
Nov 14, 2024 Q3 2024 |
614,117
shares
|
$27.5 Million
7.54% of portfolio
|
Q3 2024
Added 22.82%
|
|
Macquarie Group LTD
Australia, C3 |
Nov 14, 2024 Q3 2024 |
594,878
shares
|
$26.7 Million
0.02% of portfolio
|
Q3 2024
Added 30.75%
|
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
Nov 14, 2024 Q3 2024 |
594,876
shares
|
$26.7 Million
0.06% of portfolio
|
Q3 2024
Added 28.42%
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
Nov 14, 2024 Q3 2024 |
587,030
shares
|
$26.3 Million
0.03% of portfolio
|
Q3 2024
Reduced 1.23%
|
|
J. Goldman & CO LP
New York, NY |
Nov 14, 2024 Q3 2024 |
557,500
shares
|
$25 Million
0.57% of portfolio
|
Q3 2024
Added 44.0%
|
|
Cormorant Asset Management, LP
Boston, MA |
Nov 14, 2024 Q3 2024 |
500,000
shares
|
$22.4 Million
1.15% of portfolio
|
Q2 2024
Reduced 76.63%
|
|
Jefferies Group LLC
New York, NY |
Sep 21, 2023 Q3 2022 |
445,758
shares
|
$20 Million
0.07% of portfolio
|
Q3 2022
Added 10.68%
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 08, 2024 Q3 2024 |
440,167
shares
|
$19.7 Million
0.0% of portfolio
|
Q3 2024
Added 2088.8%
|